Tech Company Financing Transactions

Turnstone Biologics Funding Round

Turnstone Biologics, based in Ottawa Ontario, secured $41.4 million in investment from OrbiMed, F-Prime Capital and Versant Ventures.

Transaction Overview

Announced On
11/3/2016
Transaction Type
Venture Equity
Amount
$41,400,000
Round
Series B
Investors

OrbiMed (Lead Investor) (Rishi Gupta)

F-Prime Capital

Versant Ventures (Brad Bolzon)

Proceeds Purpose
The series B will support completion of the ongoing Phase I/II trial, as well as fund three additional clinical programs that will start this year and next.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
12 York St. 3rd Floor
Ottawa Ontario, K1N 5S6
Canada
Email Address
Overview
Turnstone Biologics Inc. is a biotechnology company focused on developing novel oncolytic viral immunotherapies for cancer.
Profile
Turnstone Biologics LinkedIn Company Profile
Social Media
Turnstone Biologics Company Twitter Account
Company News
Turnstone Biologics News
Facebook
Turnstone Biologics on Facebook
YouTube
Turnstone Biologics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Sammy Farah
  Sammy Farah LinkedIn Profile  Sammy Farah Twitter Account  Sammy Farah News  Sammy Farah on Facebook
Chief Financial Officer
Jane Henderson
  Jane Henderson LinkedIn Profile  Jane Henderson Twitter Account  Jane Henderson News  Jane Henderson on Facebook
Vice President
Caroline Breitbach
  Caroline Breitbach LinkedIn Profile  Caroline Breitbach Twitter Account  Caroline Breitbach News  Caroline Breitbach on Facebook
VP - Human Resources
Kristin Gustafson
  Kristin Gustafson LinkedIn Profile  Kristin Gustafson Twitter Account  Kristin Gustafson News  Kristin Gustafson on Facebook
VP - Operations
José Otero
  José Otero LinkedIn Profile  José Otero Twitter Account  José Otero News  José Otero on Facebook
VP - R & D
Michael Burgess
  Michael Burgess LinkedIn Profile  Michael Burgess Twitter Account  Michael Burgess News  Michael Burgess on Facebook
VP - R & D
Brian Lichty
  Brian Lichty LinkedIn Profile  Brian Lichty Twitter Account  Brian Lichty News  Brian Lichty on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/3/2016: Immusoft venture capital transaction
Next: 11/3/2016: Interana venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary